Omeros (OMER) Change in Inventory (2015 - 2026)

Omeros (OMER) reported Change in Inventory of $183000.0 for Q1 2026, up 168.8% sequentially from -$266000.0 in Q3 2021.

Omeros (OMER) Change in Inventory (2015 - 2026) Analysis & Trends

Omeros (OMER) has 8 years of Change in Inventory data on file, last reported at $183000.0 in Q1 2026.

For the quarter ending Q1 2026, Change in Inventory changed N/A year-over-year to $183000.0; the trailing twelve-month figure through Mar 2026 stood at -$296000.0 (up 53.97% YoY), and the FY2020 full-year result was $208000.0, down 80.36% from the prior year.
Change in Inventory climbed to $183000.0 in Q1 2026, from -$266000.0 in the prior quarter.
In the past five years, Change in Inventory ranged from a high of $183000.0 in Q1 2026 to a low of $183000.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	71.84 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	97.70 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-26.60 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Omeros	739.31 Mn	739.31 Mn	9.31 Mn	183,000.00

Download Data